The Kaiser Family Foundation hosted a panel discussion on October 3 in Washington, D.C., to explore the implications of the Centers for Disease Control and Prevention's revised recommendations on HIV testing, which say HIV tests should become a routine part of medical care for patients ages 13 to 64.

Kaiser Vice President and Director of HIV Policy Jennifer Kates moderated a panel discussion that included Bernard Branson, M.D., associate director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention; Frank Oldham, executive director, National Association of People with AIDS; Marsha Martin, senior deputy director, Administration for HIV/AIDS Policy and Programs, Department of Health, Washington, D.C.; David Holtgrave, professor and chair, Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health; and Bruce Rashbaum, M.D., Capital Medical Associates, Washington, D.C.

 Fact Sheet: HIV Testing in the United States

 CDC Revised Recommendations on HIV Testing

 CDC HIV Testing in Healthcare Settings

Webcast Materials

 Webcast

 Agenda (.pdf)

 Speaker Biographies (.pdf)

 Kates Presentation (.pdf)

 Branson Presentation (.ppt)  Select 'Read Only' to access the slides